ABT-199
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ABT-199, covering 2021-12-16 to 2023-08-21. Get the full timeline:
Most recent: Clinical Trial Update: ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM) [Phase 2]